Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 15, 2020Signal Transduction and Targeted TherapyOpen Access

Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?

View Full Paper
Ask AI
Bookmark
Share

Authors

YXYongzhi Xi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yongzhi Xi (2020) studied this question.

synapsesocial.com/papers/6aaa46d2b6ecf18e37830d4ahttps://doi.org/10.1038/s41392-020-00310-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus2019 · 241 citations
  2. 2Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies2018 · 20 citations
  3. 3Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients1999 · 421 citations
  4. 4Dengue Fever, <scp>COVID</scp>‐19 (<scp>SARS‐CoV</scp>‐2), and <scp>Antibody‐Dependent</scp> Enhancement (<scp>ADE</scp>): A Perspective2020 · 124 citations
  5. 5Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks2020 · 79 citations